Trial intelligence / Profile preview

Iodide Supplementation in Preterm Infants

NCT00638092Phase 4Completed

Sponsor
University of Oxford
Start
Mar 2010
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Sodium iodide in Transient hypothyroxinemia (THOP), sponsored by University of Oxford. Started Mar 2010; status: completed.

02

Drugs

Sodium iodide
03

Conditions

Transient hypothyroxinemia (THOP)

Beyond the preview

Go deeper on NCT00638092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00638092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call